Following completion of the Delphi process, panelists achieved consensus on 65 recommendations organized into 7 categories for which panelists faced the greatest challenges: addressing educational needs, patient identification, assessment and diagnosis, treatment, management and monitoring, administrative challenges, and other important statements. Key recommendations emphasized the importance of educating primary care physicians and other providers working with older adults to increase the urgency of identifying appropriate patients with early AD. Expert panelists recommended use of emerging blood-based biomarkers for triaging in primary care settings as well as for confirmatory diagnosis and determination of treatment eligibility, where appropriate. Consensus recommendations note that while continuation of treatment with anti-amyloid mAbs should follow prescribing information, updated guidance on maintenance treatment will be provided with continued experience and emerging clinical data.